NASDAQ: MIRA - MIRA Pharmaceuticals, Inc. Common Stock

Altı ay boyunca karlılık: +15.49%

Promosyon programı MIRA Pharmaceuticals, Inc. Common Stock

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında

MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder.

Daha fazla ayrıntı
In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Miami, Florida.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

EBITDA -6.8E-5
EV/EBITDA -1.28
IPO date 2023-08-03
Industry Pharmaceuticals
P/BV 4.46
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://mirapharmaceuticals.com
Цена ао 1.15
Число акций ао 0.01857 млрд
Günlük fiyat değişimi: -1.28% (1.17)
Haftalık fiyat değişimi: -0.431% (1.16)
Aylık fiyat değişimi: -26.9% (1.58)
3 ayda fiyat değişimi: +110.84% (0.5478)
Altı ayda fiyat değişimi: +15.49% (1.0001)
Yıllık fiyat değişimi: -75.74% (4.76)
Yılbaşından bu yana fiyat değişimi: -48.21% (2.23)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 0 0
P/BV 4.46 4
P/E 0 0
EV/EBITDA -1.75 0
Toplam: 3

Yeterlik

İsim Anlam Seviye
ROA, % -242.93 0
ROE, % -273.92 0
Toplam: 0

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA -0.000594 10
Toplam: 9.8

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 0 0
karlılık Ebitda, % 12438.31 10
karlılık EPS, % 13930.14 10
Toplam: 8
Daha fazla ayrıntı

Kurumlar Hacim Paylaşmak, %
Gts Securities LLC 37852 0.26
Praetorian Wealth Management, Inc. 27500 0.19
Northern Trust Corporation 20454 0.14
Virtu Financial LLC 14658 0.1
Sandy Spring Bank 10375 0.07
AE Wealth Management LLC 10000 0.07
Royal Bank of Canada 3500 0.02

Süpervizör İş unvanı Ödeme Doğum yılı
Mr. Erez Aminov CEO & Chairman N/A 1978 (46 yıllar)
Ms. Michelle Yanez M.B.A. CFO, Secretary & Treasurer N/A 1972 (52 yıl)
Dr. Itzchak Angel Ph.D. Chief Scientific Advisor N/A

Adres: United States, Baltimore. MD, 855 North Wolfe Street - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://mirapharmaceuticals.com